Agree. The demand will be in areas that need improved outcomes. i am thinking tendon repair where blood supply is limited. Think of the tendo Achilles a major foot ankle tendon. for a footballer it could be the end of a career. Surgeons will use our products to strengthen tendon repairs and get better outcomes. DW has mentioned rotator cuff repair which is a huge area. Breast reconstruction is again a major area. Females with the BRCA gene mutation for breast are now having elective mastectomies and reconstruction at the same time. This is where our products can help a good cause. Hernias are not that lucrative and as pointed out there are cheap options in the market.
PNV v ARX, page-64
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.60 |
Change
-0.010(0.38%) |
Mkt cap ! $1.804B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.58 | $780.4K | 299.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 16543 | $2.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 24754 | 20 |
View Market Depth
| Last trade - 13.27pm 19/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |